Assessing the Relationship Between Symptoms and Mitral Regurgitnant. Severity

Last updated: December 13, 2024
Sponsor: Atlantic Health System
Overall Status: Active - Recruiting

Phase

N/A

Condition

Mitral Valve Regurgitation

Treatment

Kansas City Cardiomyopathy Questionairre

Pressure volume loop evaluation

cardiovascular magnetic resonance imaging

Clinical Study ID

NCT06738615
2223778
  • Ages > 18
  • Male

Study Summary

The current American College of Cardiology/American Heart Association (ACC/AHA) guidelines recommend surgery in patient with mitral regurgitation (MR) based on 1) the severity of MR and 2) the presence or absence of symptoms. Studies have shown that Cardiovascular Magnetic Resonance (CMR) is an accurate method to quantify the severity of MR. However, studies have also shown that symptoms are not necessarily related to the presence of symptoms. Thus, there appears to be a disconnect between the severity of MR and symptoms. Recent analysis of our data has shown that females and older patients with smaller ventricles, lower stroke volumes, and lower regurgitant volume relative to regurgitant fraction tend to be symptomatic. These findings suggest that decreased left ventricular compliance, i.e. diastolic dysfunction, may play an important role as an etiology of symptoms in patients with mitral regurgitation. The aim of this study is to study the presence of diastolic dysfunction in patients with MR and its association with symptom burden and exercise capacity.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Age >=18 years of age

  • Able to give informed consent

  • Primary (degenerative) mitral regurgitation

  • LVEF >=50%

  • Undergoing cardiac catheterization

  • Able to exercise on a treadmill

Exclusion

Exclusion Criteria:

  • Unable to give informed consent

  • Secondary (functional) mitral regurgitation

  • LVEF <50%

  • Known coronary artery stenosis >=70% or past revascularization

  • More than mild aortic stenosis, mitral stenosis, aortic regurgitation, tricuspidregurgitation, or pulmonic regurgitation

  • Hypertrophic cardiomyopathy

  • Pregnancy

Study Design

Total Participants: 40
Treatment Group(s): 4
Primary Treatment: Kansas City Cardiomyopathy Questionairre
Phase:
Study Start date:
January 02, 2025
Estimated Completion Date:
May 02, 2027

Study Description

The study is an observational study of patients with mitral regurgitation undergoing LHC prior to mitral valve surgery or percutaneous mitral valve intervention. Prior to patients LHC they will undergo testing using CMR, CPET, and KCCQ. During the LHC, patients will undergo evaluation of intracardiac pressures and volumes using a specialized catheter which measures pressure and volume changes throughout the cardiac cycle.

CMR- CMR evaluation will quantify mitral regurgitant volume and fraction, right and left atrial size and function, and myocardial scar quantification.

CPET- objectively assess patients exercise capacity. KCCQ- is a standard questionnaire designed to assesses patients quality of life and symptom burden.

LHC- Pressure-volume loops will be measured during LHC. This will quantify left ventricular compliance and assess patients for the presence of diastolic dysfunction.

These evaluations will help us better understand the relationship between symptoms, exercise capacity, severity of MR and diastolic dysfunction.

Connect with a study center

  • Morristown Medical Center

    Morristown, New Jersey 07960
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.